References
- L.B. Baradell, D. Faulds and D. McTavish, Lansoprasole: A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders, Drugs, 44, 225-250 (1992) https://doi.org/10.2165/00003495-199244020-00007
- A.E. Zimmermann and B.G. Katona, Lansoprazole: A comprehensive review, Pharmacotherapy, 17, 308-326 (1997)
- A. Kristl and F. Vrecer, Preformulation investigation of the novel proton pump inhibitor lansoprazole, Drug Dev. Ind. Pharm., 26, 781-783 (2000) https://doi.org/10.1081/DDC-100101299
- T. Tabata, T. Makino, T. Kashihara, S. Hirai, N. Kitamori and H. Toguchi, Stabilization of a new antiulcer drug (lansoprazole) in the solid dosage forms, Drug Dev. Ind. Pharm., 18, 1437-1447 (1992) https://doi.org/10.3109/03639049209040850
- A.B. Robert, Lansoprazole and omeprazole in the treatment of acid peptic disorders, Am. J. Health-Syst. Pharm., 53, 1401-1415 (1996)
- T. Tabata, T. Makino, J. Kikuta, S. Hirai and N. Kitamori, Manufacturing method of stable enteric granules of a new antiulcer drug (lansoprazole), Drug Dev. Ind. Pharm., 20, 1661-1672 (1994) https://doi.org/10.3109/03639049409050206
- M.A. Bayomi, S.A. Al-Suwayeh and A.R. El-Helw, Excipient-excipient interaction in the design of sustained-release theophylline tablets: In vitro and in vivo evaluation, Drug Dev. Ind. Pharm., 27, 499-506 (2001) https://doi.org/10.1081/DDC-100105174
- N.N. Salib and S.A. El-Gamal, Application of some polymers in the physiocochemical design of tablet formulation, Die Pharmazie, 31, 718-721 (1976)
- A.M. Sakr, H.M. Elsabbagh and A.H. Shalaby, Effect of the technique of incorporating sodium alginate on its binding and/or disintegrating effectiveness in sulfathiazole tablets, Pharm. Ind., 40, 1080-1086 (1978)
- K.A. Khan and C.T. Rhodes, Disintegration properties of calcium phosphate dibasic dihydrate tablets, J. Pharm. Sci., 64, 166-168 (1975) https://doi.org/10.1002/jps.2600640141
- P. Veski and M. Marvola, Sodium alginates as diluents in hard gelatin capsules containing ibuprofen as a model drug, Pharmazie, 48, 757-760 (1993)
- S. Klaudianos, Alginate sustained-action tablets, Dtsch Apoth Ztg, 118, 683-684 (1978)
- Bodmeier and J. Wang, Microencapsulation of drugs with aqueous colloidal polymer dispersions, J. Pharm. Sci., 82, 191-194 (1993) https://doi.org/10.1002/jps.2600820215
- F. Lim and R.D. Moss, Microencapsulation of living cells and tissues, J. Pharm. Sci., 70, 351-354 (1981) https://doi.org/10.1002/jps.2600700402
- M. Rajaonarivony, C. Vauthier, G. Couarraze, F. Puisieux and P. Couvreur, Development of a new drug carrier made from alginate, J. Pharm. Sci., 82, 912-917 (1993) https://doi.org/10.1002/jps.2600820909
- R. Bodmeier, H.G. Chen and O. Paeratakul, A novel approach to the oral delivery of micro- or nanoparticles, Pharm. Res., 6, 413-417 (1989) https://doi.org/10.1023/A:1015987516796
- W.R. Gombotz and S.F. Wee, Protein release from alginate matrices, Adv. Drug Delivery Rev., 31, 267-285 (1998) https://doi.org/10.1016/S0169-409X(97)00124-5
- T. Yotsuyanagi, T. Ohkubo, T. Ohhashi and K. Ikeda, Calcium-induced gelation of alginic acid and pH-sensitive reswelling of dried gels, Chem. Pharm. Bull., 35, 1555-1563 (1987) https://doi.org/10.1248/cpb.35.1555
- A.H. Kibbe, Handbook of Pharmaceutical Excipients, 3rd Ed., 465-467 (2000)
- R.J. Mumper, A.S. Hoffman, P. Puolakkainen, L.S. Bouchard and W.R. Gombotz, Calcium-alginate beads for the oral delivery of transforming growth factor-1: Stabilization of TGF-1 by the addition of polyacrylic acid within acid-treated beads, J. Control. Rel., 30, 241-251 (1994) https://doi.org/10.1016/0168-3659(94)90030-2
- C.K. Kim and E.J. Lee, The controlled release of blue dextran from alginate bead, Int. J. Pharm., 79, 11-19 (1992) https://doi.org/10.1016/0378-5173(92)90088-J
- S. Sugawara, R. Imai and M. Otagiri, The controlled release of prednisolone using alginate gel, Pharm. Res., 11, 272-277 (1994) https://doi.org/10.1023/A:1018963626248
- V. Pillay, R. Fassihi, In vitro release modulation from crosslinked pellets for site-specific drug delivery to the gastrointestinal tract I. Comparison of pH-responsive drug release and associated kinetics, J. Control. Rel., 59, 229-242 (1999) https://doi.org/10.1016/S0168-3659(98)00196-5